SSF grant for strategic mobility to Mikael Kubista

Researcher Mikael Kubista receives SEK 1,500,000 from SSF, for a project in large-scale multimarker profiling in collaboration with researchers at the Institute of Biomedicine. The goal is to establish a powerful platform for basic research, that can be translated to clinical routine diagnostics and also become a powerful tool for substance screening in drug development. This state-of-the-art service platform will provide robust, low-cost, high-throughput workflows for molecular multimarker analysis that includes cell and gene therapy drug targets as well as quality control software. The project complements the workflows already developed at the Institute of Biomedicine. The quality control analysis will be implemented in software products. Some of the solutions will be commercialized through licensing.